Azurity Pharmaceuticals recalls
4 official recalls and safety alerts involving Azurity Pharmaceuticals since 2021-10, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.
This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Azurity Pharmaceuticals or the relevant agency.
- 2024-02-07
US- 2024-01-10
- US
Azurity Pharmaceuticals, Inc. recalls Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA…
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
- 2023-04-12
- US
Azurity Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL…
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
- 2021-10-13
- US
Azurity Pharmaceuticals, Inc. recalls Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g…
Product Mix-up: Incorrect diluent component included in the kit.